Steven Roberds, PhD, leads the development and execution of the Tuberous Sclerosis Alliance scientific strategy through partnerships with individuals affected by tuberous sclerosis complex (TSC), researchers, healthcare providers, government agencies, nonprofits and other stakeholders. As chief scientific officer since 2011, he leads the creation and growth of the TSC Preclinical Consortium to accelerate testing of new treatments and the TSC Biosample Repository.